Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,778,019
  • Shares Outstanding, K 52,046
  • Annual Sales, $ 1,102 M
  • Annual Income, $ 12,480 K
  • 60-Month Beta 1.18
  • Price/Sales 3.47
  • Price/Cash Flow 14.16
  • Price/Book 4.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.63
  • Number of Estimates 8
  • High Estimate 0.66
  • Low Estimate 0.61
  • Prior Year 0.69
  • Growth Rate Est. (year over year) -8.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.48 +10.75%
on 10/25/19
73.92 -1.89%
on 11/18/19
+5.99 (+9.00%)
since 10/18/19
3-Month
60.35 +20.17%
on 10/02/19
73.92 -1.89%
on 11/18/19
+8.52 (+13.31%)
since 08/19/19
52-Week
43.51 +66.67%
on 01/08/19
73.92 -1.89%
on 11/18/19
+11.21 (+18.28%)
since 11/19/18

Most Recent Stories

More News
Zimmer (ZBH) Hits 52-Week High: What's Driving the Stock?

Zimmer (ZBH) is optimistic about maintaining its growth momentum on several recent positive developments.

ZBH : 144.54 (-0.31%)
HAE : 120.84 (+1.44%)
NUVA : 72.52 (-0.10%)
RMD : 149.39 (+1.09%)
Medtronic (MDT) Beats on Q2 Earnings, Ups FY20 EPS Guidance

Medtronic (MDT) demonstrates improved performances at CER, banking on growth in all major business segments and geographies.

TMO : 306.42 (+1.80%)
MDT : 111.07 (-0.16%)
NUVA : 72.52 (-0.10%)
RMD : 149.39 (+1.09%)
Edwards Lifesciences (EW) Recalls PASCAL's Guide Sheath

Edwards Lifesciences (EW) issues a product recall for its guide sheath based on report from its urgent field safety notice.

NUVA : 72.52 (-0.10%)
HAE : 120.84 (+1.44%)
EW : 243.56 (+0.49%)
RMD : 149.39 (+1.09%)
QIAGEN Rides on Solid QuantiFERON-TB Sales Amid Several Woes

QIAGEN (QGEN) pins hopes on its key strategic collaborations with Hamilton Robotics and Tecan for the pre-analytical handling of blood tubes.

HAE : 120.84 (+1.44%)
RMD : 149.39 (+1.09%)
NUVA : 72.52 (-0.10%)
QGEN : 41.04 (-0.02%)
Amedisys Partners With nVoq to Improve Clinician Experience

Amedisys (AMED) aims to enhance clinician workflow by integrating nVoq's technology platform into its home health business.

HAE : 120.84 (+1.44%)
RMD : 149.39 (+1.09%)
NUVA : 72.52 (-0.10%)
AMED : 154.15 (-0.50%)
Canopy Growth (CGC) Q2 Earnings & Revenues Miss Estimates

Canopy Growth (CGC) reports mixed fiscal second-quarter results on strength in its core segments.

TMO : 306.42 (+1.80%)
NUVA : 72.52 (-0.10%)
RMD : 149.39 (+1.09%)
CGC : 15.32 (+7.74%)
Haemonetics (HAE) Grows on New Products, Robust Plasma Sales

Haemonetics (HAE) witnesses a steady uptick in Plasma franchise, fueled by favorable price, volume and mix.

EW : 243.56 (+0.49%)
NUVA : 72.52 (-0.10%)
GWPH : 103.56 (+1.06%)
HAE : 120.84 (+1.44%)
Insulet (PODD) Hits a 52-Week High: What's Driving the Stock?

Insulet (PODD) has been gaining from several positive developments recently.

HAE : 120.84 (+1.44%)
PODD : 180.89 (-0.88%)
RMD : 149.39 (+1.09%)
NUVA : 72.52 (-0.10%)
Here's Why You Should Hold on to CVS Health (CVS) For Now

Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

NUVA : 72.52 (-0.10%)
HAE : 120.84 (+1.44%)
GWPH : 103.56 (+1.06%)
CVS : 75.35 (+0.33%)
CVS Health's New Plans With Aetna May Improve Health Outcomes

CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

NUVA : 72.52 (-0.10%)
HAE : 120.84 (+1.44%)
GWPH : 103.56 (+1.06%)
CVS : 75.35 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NUVA with:

Business Summary

NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical...

See More

Key Turning Points

2nd Resistance Point 73.89
1st Resistance Point 73.20
Last Price 72.52
1st Support Level 72.03
2nd Support Level 71.55

See More

52-Week High 73.92
Last Price 72.52
Fibonacci 61.8% 62.30
Fibonacci 50% 58.71
Fibonacci 38.2% 55.13
52-Week Low 43.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar